Poolbeg Pharma PLC Announces US Patents Granted for POLB 001 and POLB 002
Further Expansion of IP Portfolio Enhancing Protection of Poolbeg's Growing PipelineLONDON, UK / ACCESSWIRE / May 26, 2022 / Poolbeg...
Further Expansion of IP Portfolio Enhancing Protection of Poolbeg's Growing PipelineLONDON, UK / ACCESSWIRE / May 26, 2022 / Poolbeg...
SEATTLE--(BUSINESS WIRE)--#EHR--Health and Social Care Northern Ireland (HSCNI) has enlisted the support of global healthcare technology specialist, Tegria, and digital...
Strong revenue and cash flow growth driven by continued momentum in core business and investment in expanded capabilities Total revenue...
Whistleblowers who have information about EHR fraud may bring lawsuits under the False Claims Act. WASHINGTON--(BUSINESS WIRE)--Today, the national law...
First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND,...
Charlotte, North Carolina--(Newsfile Corp. - May 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
Bloomington, Indiana--(Newsfile Corp. - May 25, 2022) - SummaForte has added two respected experts in sports medicine and physical therapy...
Montreal, Quebec--(Newsfile Corp. - May 25, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTC Pink: ELIXF) ("Elixxer" or the "Company) is...
NEW YORK--(BUSINESS WIRE)--Nym Health, a leader in transforming clinical language into actionable information, today announced that its Senior Vice President...
For the third straight year, Lumenis wins award recognizing outstanding medical companies and technologies YOKNE’AM ILLIT, Israel--(BUSINESS WIRE)--Lumenis Be., a...
Nation's Largest Urgent Care Provider Appoints Paige Robinson to Lead Expansion EffortsBIRMINGHAM, AL / ACCESSWIRE / May 25, 2022 /...
The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing...
STOCKHOLM, SWEDEN / ACCESSWIRE / May 25, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to...
CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology...
Progressing broad vaccine development program in collaboration with GSK, with second-generation candidates in Phase 1 clinical trials for COVID-19 and...
LOS GATOS, CA / ACCESSWIRE / May 25, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device...
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,...
Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof...
Capricor Expands Senior Management Team to Build Commercial Strategy for Lead Asset, CAP-1002, and Further Develop Partnering Strategy for Proprietary...